PERSPECTA

News from every angle

← Back to headlines

Avalo Therapeutics CMO Mittie Doyle Sells Stock

Mittie Doyle, CMO of Avalo Therapeutics, has sold $13,580 worth of company stock.

15 Aug, 15:37 — 15 Aug, 15:37
PostShare

Sources

Showing 1 of 1 sources
investing-com3d ago

Avalo Therapeutics CMO Mittie Doyle sells $13,580 in stock - Investing.com

Avalo Therapeutics CMO Mittie Doyle sells $13,580 in stock  Investing.com

Read full article →

Related Stories

Anthropic's Revenue Soars to $65 Billion Ahead of IPO

27m ago

Farmers Accuse Officials of Failing to Address Drought Severity

33m ago

US Pending Home Sales Plunge to Near Record Lows in July

1h ago

Pakistan Government Hikes Petrol and Diesel Prices

1h ago